The effect of empagliflozin on all-cause mortality and hospitalization for heart failure will be evaluated in the in phase 3 EMPACT-MI study.
For patients with diabetes, coronary artery calcium predicts cardiovascular disease and total mortality more strongly in women than men.
The approval was based on data from the randomized, double-blind, parallel-arm phase 3 AWARD-11 trial.
Coronary artery bypass grafting was associated with improved long-term mortality and freedom from MACCEs compared with percutaneous coronary intervention in patients with diabetes.
Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.
Researchers sought to determine whether triglyceride levels were independently associated with cardiovascular disease among patients with coronary artery disease and type 2 diabetes.
The effects of the COVID-19 pandemic on the diagnosis and presentation of pediatric type 1 diabetes.
The long-acting human insulin analogue has an identical amino acid sequence to Lantus® (insulin glargine; Sanofi).
The FDA concluded “the risk no longer meets the standard for a Boxed Warning.”
Type 2 diabetes may negatively impact bone density around the age of peak bone mass.